HGHenry Randall Griffith

Henry Randall Griffith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Henry Randall Griffith has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Jan A. Den Hollander

    Departments of Cardiology , University of Alabama at Birmingham , Birmingham, AL, USA

    8 shared publications
  • Daniel C. Marson

    Department of Neurology, University of Alabama at Birmingham, USA

    7 shared publications
  • John C. Brockington

    Departments of Neurology , University of Alabama at Birmingham , Birmingham, AL, USA ; Alzheimer's Disease Research Center , University of Alabama at Birmingham , USA

    6 shared publications
  • Lindy E. Harrell

    Departments of Neurology , University of Alabama at Birmingham , Birmingham, AL, USA ; Alzheimer's Disease Research Center , University of Alabama at Birmingham , USA ; Birmingham Regional Veterans Affairs Medical Center , Birmingham, AL, USA

    6 shared publications
  • Ozioma C. Okonkwo

    From the Departments of *Neurology, †Psychology, and #Cardiology, and ‡Alzheimer's Disease Research Center, University of Alabama at Birmingham, Birmingham, Alabama; §Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; ∥Department of Neurology, School of Medicine, the Johns Hopkins University, Baltimore, Maryland; and **Birmingham Regional Veterans Affairs Medical Center, Birmingham, Alabama

    4 shared publications
  • Roy C. Martin

    From the Departments of *Neurology, †Psychology, and #Cardiology, and ‡Alzheimer's Disease Research Center, University of Alabama at Birmingham, Birmingham, Alabama; §Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; ∥Department of Neurology, School of Medicine, the Johns Hopkins University, Baltimore, Maryland; and **Birmingham Regional Veterans Affairs Medical Center, Birmingham, Alabama

    4 shared publications

Latest Publications

  • Open Access

    Brain Metabolic Correlates of Decision Making in Amnestic Mild Cognitive Impairment

    by H. Randall Griffith, Ozioma C. Okonkwo, Jan A. Den Hollander, Katherine Belue, Jacqueline Copeland, Lindy E. Harrell, John C. Brockington, David G. Clark, Daniel C. Marson

    Persons with amnestic mild cognitive impairment (MCI) have subtle impairments in medical decision-making capacity (MDC). We examined the relationship between proton magnetic resonance spectroscopy (MRS) and MDC in MCI. Twenty-nine MCI patients and 42 controls underwent MRS to obtain ratios of N-acetylaspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, and myo-Inositol (mI)/Cr of the posterior cingulate. They also completed the Capacity to Consent to Treatment Instrument (CCTI), a vignette-based instrument measuring decisional standards of expressing choice, appreciating consequences of choice, providing rational reasons for choice, and understanding treatment choices. Patients showed abnormal MRS ratios of mI/Cr and Cho/Cr compared to controls, and impairments on the CCTI understanding and reasoning Standards. Performance on the reasoning standard of the CCTI was correlated with NAA/Cr (r = .46, p < .05). The relationship of NAA/Cr with decision-making suggests a role for posterior cortical neuronal functioning in performance of complex IADLs in MCI.


  • Open Access

    Magnetic Resonance Imaging Volume of the Angular Gyri Predicts Financial Skill Deficits in People with Amnestic Mild Cognitive Impairment

    by H. Randall Griffith, Christopher C. Stewart, Luke E. Stoeckel, Ozioma C. Okonkwo, Jan A. Den Hollander, Roy C. Martin, Katherine Belue Bs, Jacquelynn N. Copeland, Lindy E. Harrell, John C. Brockington, et al.

    OBJECTIVES: To better understand how brain atrophy in amnestic mild cognitive impairment (MCI) as measured using magnetic resonance imaging (MRI) volumetrics could affect instrumental activities of daily living (IADLs) such as financial abilities. DESIGN: Controlled, matched‐sample, cross‐sectional analysis regressing MRI volumetrics with financial performance measures. SETTING: University medical and research center. PARTICIPANTS: Thirty‐eight people with MCI and 28 older adult controls. MEASUREMENTS: MRI volumetric measurement of the hippocampi, angular gyri, precunei, and medial frontal lobes. Participants also completed neuropsychological tests and the Financial Capacity Instrument (FCI). RESULTS: Correlations were performed between FCI scores and MRI volumes in the group with MCI. People with MCI performed significantly below controls on the FCI and had significantly smaller hippocampi. Among people with MCI, performance on the FCI was moderately correlated with angular gyri and precunei volumes. Regression models demonstrated that angular gyrus volumes were predictive of FCI scores. Tests of mediation showed that measures of arithmetic and possibly attention partially mediated the relationship between angular gyrus volume and FCI score. CONCLUSION: Impaired financial abilities in amnestic MCI correspond with volume of the angular gyri as mediated by arithmetic knowledge. The findings suggest that early neuropathology within the lateral parietal region in MCI leads to a breakdown of cognitive abilities that affect everyday financial skills. The findings have implications for diagnosis and clinical care of people with MCI and AD.


  • Open Access

    The Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease

    by Timothy J. O'Brien, Virginia Wadley, Anthony P. Nicholas, Natividad P. Stover, Ray Watts, H. Randall Griffith

    Deficits in learning, memory, and executive functions are common cognitive sequelae of Parkinson's disease with dementia (PDD) and Alzheimer's disease (AD); however, the pattern of deficits within these populations is distinct. Hierarchical regression was used to investigate the contribution of two measures with executive function properties (Verbal Fluency and CLOX) on list-learning performance (CVLT-II total words learned) in a sample of 25 PDD patients and 25 matched AD patients. Executive measures were predictive of list learning in the PDD group after the contribution of overall cognition and contextual verbal learning was accounted for, whereas in the AD group the addition of executive measures did not add to prediction of variance in CVLT-II learning. These findings suggest that deficits in executive functions play a vital role in learning impairments in patients with PDD; however, for AD patients, learning difficulties appear relatively independent of executive dysfunction.


  • Contributions of volumetrics of the hippocampus and thalamus to verbal memory in temporal lobe epilepsy patients

    by Christopher C. Stewart, H. Randall Griffith, Ozioma C. Okonkwo, Roy C. Martin, Robert K. Knowlton, Elizabeth J. Richardson, Bruce P. Hermann, Michael Seidenberg


  • Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

    by H. Randall Griffith, Jan A. Den Hollander, Ozioma C. Okonkwo, Timothy O'BRien, Ray L. Watts, Daniel C. Marson

    Background: Few comparative studies exist of metabolic brain changes among neurodegenerative illnesses. We compared brain metabolic abnormalities in Alzheimer's disease (AD) and in Parkinson's disease with dementia (PDD) as measured by proton magnetic resonance spectroscopy (MRS).Methods: Twelve patients with idiopathic PDD, 22 patients with probable mild AD, and 61 healthy older controls underwent posterior cingulate MRS.Results: Patients with AD exhibited reduced N‐acetyl aspartate (NAA)/creatine (Cr) (P < .05) and increased choline (Cho)/Cr (P < .05) and myo‐inositol (mI)/Cr (P < .01) compared with controls. Patients with PDD exhibited reduced NAA/Cr (P < .05) and glutamate (Glu)/Cr (P < .01) compared with controls. There was reduced Glu/Cr in PDD compared with AD (P < .01).Conclusions: Patients with AD and patients with PDD exhibited distinct brain metabolic MRS profiles. Findings suggest that comparison of brain MRS profiles across dementias provides useful direction for future study.


  • The safety and tolerability of galantamine in patients with epilepsy and memory difficulties

    by H. Randall Griffith, Roy Martin, Stephanie Andrews, A. LeBron Paige, Janice Ware, Edward Faught, Timothy Welty


  • Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia

    by Henry Randall Griffith, Jan A. Den Hollander, Ozioma C. Ma Okonkwo, Timothy Ba O'Brien, Ray L. Watts, Daniel C. Jd Marson

    Persons with Parkinson disease (PD) are at risk of developing dementia. Of the dementias affecting patients with PD, PD with dementia (PDD) is not well understood, although brain imaging studies to date have observed characteristic patterns of brain atrophy. Metabolic differences have been observed in magnetic resonance spectroscopy (MRS) studies comparing patients with PDD to nondemented PD patients, although it is unclear whether PDD patients have abnormally low MRS ratios compared with healthy age-matched adults. In this study, 12 patients with PDD, 12 patients with PD and no dementia, and 12 age-matched healthy older adults underwent MRS of the posterior cingulate gyrus. Patients with PDD showed lower N-acetylaspartate/creatine (NAA/Cr) compared with controls (P=0.004) and compared with nondemented PD patients (P=0.003). No abnormalities were observed in choline/Cr or myo-Inositol/Cr. NAA/Cr was correlated with mental status in patients with PD and in patients with PDD (r=0.56; P=0.029). The findings suggest that reduced NAA/Cr of the posterior cingulate could be used as a marker for dementia in patients with PD. Future studies investigating the utility of brain MRS as a predictor of dementia in PD and comparing brain metabolism in PDD with other dementias seem warranted.


  • Reduced brain glutamate in patients with Parkinson's disease

    by H. Randall Griffith, Ozioma C. Okonkwo, Timothy O'BRien, Jan A. Den Hollander

    An understanding of the role played by glutamate (Glu) in idiopathic Parkinson's disease (PD) has remained somewhat elusive. Animal models of PD suggest that over‐activity of Glu receptors complicates the motor symptoms of PD and that Glu blockade may be a pharmacologic target in PD, whereas patient autopsy studies have proved less convincing for changes in Glu. No previous 1H MRS patient studies have documented changes in glutamate. All but one of these previous studies were performed at 1.5 T. We performed 3 T 1H MRS of the posterior cingulate gyrus in 12 non‐demented patients with PD and 12 age‐matched, neurologically normal control participants. Glu, N‐acetylaspartate (NAA) and choline‐containing compounds (Cho) measured in reference to creatine + phosphocreatine (Cr) were determined from single‐voxel proton MR spectra measured by PRESS at TE of 80 ms. The results show that the Glu/Cr ratio was reduced in patients with PD compared with controls (t = 2.54; P = 0.019), whereas no differences were observed in NAA/Cr or Cho/Cr ratios. These findings suggest that a reduction in Glu occurs in the cerebral cortex of patients with PD. 1H MRS at 3 T should be investigated in future studies as a means of tracking the course of metabolic brain changes in association with progression of disease in patients with PD. Copyright © 2007 John Wiley & Sons, Ltd.


  • Executive function is associated with brain proton magnetic resonance spectroscopy in amnestic mild cognitive impairment

    by H. Randall Griffith, Jan A. Den Hollander, Ozioma Okonkwo, William T. Evanochko, Lindy E. Harrell, Edward Y. Zamrini, John C. Brockington, Daniel C. Marson

    Persons with amnestic mild cognitive impairment (MCI) show deficits on executive function measures, although the neuroanatomic basis of executive function in MCI is unknown. We investigated cognitive correlates of 3-tesla proton magnetic resonance spectroscopy (MRS) of the posterior cingulate gyrus in 26 MCI patients. Posterior cingulate ratio of myo-inositol to creatine (mI/Cr) was negatively correlated (−.51) with spontaneous clock drawing. This relationship was not attenuated after accounting for age, overall cognitive function, or memory performance. This finding suggests a role for the posterior cingulate in executive function in MCI. Proton MRS may offer a means to track neurometabolic changes associated with cognitive impairment in MCI.